A retrospective observational study on biological drug treatment in a daily practice serving patients with psoriasis in Japan

Chika OhataDepartment of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, JapanCorrespondence[email protected]

Bungo OhyamaDepartment of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan

Aya NanriDepartment of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan

Takako ShintaniDepartment of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan

Takekuni NakamaDepartment of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan

References

Ohata C, Ohyama B, Nagata H, et al. Successful treatment with adalimumab in a patient with psoriasis vulgaris after infliximab-related liver injury. J J Expt Derm Res. 2015;10:14.
Google Scholar
Ohata C, Shintani T, Arakawa M, et al. Frequent office visits for injections may reduce adalimumab survival rate in patients with psoriasis. J Dermatolog Treat. 2015;26:312–313.
PubMed Web of Science ®Google Scholar
Umezawa Y, Nobeyama Y, Hayashi M, et al. Drug survival rates in patients with psoriasis after treatment with biologics. J Dermatol. 2013;40:1008–1013.
PubMed Web of Science ®Google Scholar
Gniadecki R, Bang B, Bryld LE, et al. Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris. Br J Dermatol. 2015;172:244–252.
PubMed Web of Science ®Google Scholar
Vilarrasa E, Notario J, Bordas X, et al. ORBIT (outcome and retention rate of biologic treatments for psoriasis): a retrospective observational study on biologic drug survival in daily practice. J Am Acad Dermatol. 2016;74:1066–1072.
PubMed Web of Science ®Google Scholar
Esposito M, Gisondi P, Cassano N, et al. Survival rate of antitumour necrosis factor-alpha treatments for psoriasis in routine dermatological practice: a multicentre observational study. Br J Dermatol. 2013;169:666–672.
PubMed Web of Science ®Google Scholar
Menting SP, Sitaram AS, Bonnerjee-van der Stok HM, et al. Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis. Br J Dermatol. 2014;171:875–883.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A retrospective observational study on biological drug treatment in a daily practice serving patients with psoriasis in Japan

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A retrospective observational study on biological drug treatment in a daily practice serving patients with psoriasis in Japan

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date